13F Data
13F filer · CIK 1882053

BOONE CAPITAL MANAGEMENT LLC

ATLANTA, GA · filing since Q4 2022 · last filing Aug 14, 2026
Reported value
$427.5M
+$101.1M vs prior
Positions
16
New / sold out
7 / 4
Added / reduced
8 / 1
Turnover
20.3%
buys $147.2M · sells $76.7M
Top-10 weight
83.0%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
NewVESTIS CORPORATION+1,900,140–+$27.6M
NewPENNANT GROUP INC+515,818–+$19.1M
NewMONTE ROSA THERAPEUTICS INC+615,287–+$14.9M
NewTANGO THERAPEUTICS INC+455,605–+$14.2M
AddedTELEFLEX INCORPORATED+108,596+39.0%+$13.8M
NewKYMERA THERAPEUTICS INC+113,173–+$13.0M
NewCULLINAN THERAPEUTICS INC+704,442–+$12.8M
AddedBRIDGEBIO PHARMA INC+110,891+48.5%+$8.3M
AddedTHE CIGNA GROUP+21,768+15.8%+$6.0M
AddedUNITEDHEALTH GROUP INC+9,461+11.9%+$3.9M
5 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
Sold outMEDTRONIC PLC-398,065-100.0%$-34.5M
Sold outASTRAZENECA PLC-110,101-100.0%$-21.7M
Sold outAVANOS MED INC-1,184,909-100.0%$-16.6M
Sold outTENAX THERAPEUTICS INC-200,000-100.0%$-3.2M
ReducedMIRUM PHARMACEUTICALS INC-5,595-1.3%$-655.0K

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2022: $194.9MQ1 2023: $213.6MQ2 2023: $278.6MQ3 2023: $317.0MQ4 2023: $428.4MQ1 2024: $494.4MQ2 2024: $383.4MQ3 2024: $385.8MQ4 2024: $296.5MQ1 2025: $293.8MQ2 2025: $233.2MQ3 2025: $305.0MQ4 2025: $318.6MQ1 2026: $326.4MQ2 2026: $427.5M
Q4 2022Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1TELEFLEX INCORPORATEDCOM387,388$49.1M11.49%
2MIRUM PHARMACEUTICALS INCCOM415,641$48.7M11.38%
3THE CIGNA GROUPCOM159,290$43.9M10.27%
4IONIS PHARMACEUTICALS INCCOM519,977$41.2M9.64%
5UNITEDHEALTH GROUP INCCOM88,687$36.9M8.62%
6BIOMARIN PHARMACEUTICAL INCCOM583,219$33.4M7.81%
7GUARDIAN PHARMACY SVCS INCCL A711,939$29.8M6.97%
8VESTIS CORPORATIONCOM SHS1,900,140$27.6M6.45%
9BRIDGEBIO PHARMA INCCOM339,720$25.3M5.92%
10PENNANT GROUP INCCOM515,818$19.1M4.46%
6 more rows. Subscribe for $29/month to see every row, download the data and use the API.